Ad-hoc | 23 March 2021 12:10

Geratherm Medical AG: 2020 – Best financial year so far (preliminary business figures)

Geratherm Medical AG / Key word(s): Annual Results
Geratherm Medical AG: 2020 – Best financial year so far (preliminary business figures)

23-March-2021 / 12:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of insider information in accordance with Article 17 MAR,
transmitted by DGAP – a service of EQS-Group AG

2020 – Best financial year so far (preliminary business figures)

– Revenues EUR 27.5 million +38.4%

– EBITDA 4,347 kEUR + 84.7%

– EBITDA-Margin 15.8% + 32.8%

– Operating profit (EBIT) 3,039 kEUR +189.7%

– result from ordinary operations 2,719 kEUR +161.9%

– Earnings per share 41 cents (previous year: 11 cents)

– Return on equity 10.3%

– Equity ratio 55.4%

– Cash and securities EUR 10.3 million

– Proposed dividend: 40 cents per share

– Still strong international demand for Geratherm medical products

Geratal, March 23, 2021: Geratherm Medical AG (ISIN: DE0005495626) had a very good performance, especially in the last 9 months of 2020 financial year. Sales increased by +38.4%. The result from ordinary business operations clearly increased to more than double.

All product segments had a strong increase in sales. Healthcare Diagnostic EUR 18.4 million, +40.1%; Respiratory EUR 4.8 million, +14.2%; Medical warming systems EUR 2.4 million, +184.2%; Cardio/Stroke 1.9 million EUR, +11.0%.

The detailed Annual Report 2020 will be published on April 28, 2021.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Dr. Gert Frank; Dipl.-Kfm. Christian Frick
Aufsichtsratsvorsitzender: Dipl.-Kfm. Rudolf Bröcker
Tel. 036205/98 0
E-Mail: info@geratherm.com
www.geratherm.com

Short company profil :
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company’s roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MRI Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.

Contact:
Dr. Gert Frank

23-March-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Geratherm Medical AG
	Fahrenheitstraße 1
	99331 Geratal
	Germany
Phone:	+49 (0)36205 98-0
Fax:	+49 (0)36205 98-1 15
E-mail:	info@geratherm.com
Internet:	www.geratherm.com
ISIN:	DE0005495626
WKN:	549562
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	1177537

End of Announcement DGAP News Service